Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Insights into cytokine-receptor interactions from cytokine engineering
Jamie B Spangler1, Ignacio Moraga, Juan L Mendoza
1Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305; email: kcgarcia@stanford.edu , jamie.spangler@stanford.edu , imoraga@stanford.edu , juan.mendoza@stanford.edu.
Abstract:
Cytokines exert a vast array of immunoregulatory actions critical to human biology and disease. However, the desired immunotherapeutic effects of native cytokines are often mitigated by toxicity or lack of efficacy, either of which results from cytokine receptor pleiotropy and/or undesired activation of off-target cells. As our understanding of the structural principles of cytokine-receptor interactions has advanced, mechanism-based manipulation of cytokine signaling through protein engineering has become an increasingly feasible and powerful approach. Modified cytokines, both agonists and antagonists, have been engineered with narrowed target cell specificities, and they have also yielded important mechanistic insights into cytokine biology and signaling. Here we review the theory and practice of cytokine engineering and rationalize the mechanisms of several engineered cytokines in the context of structure. We discuss specific examples of how structure-based cytokine engineering has opened new opportunities for cytokines as drugs, with a focus on the immunotherapeutic cytokines interferon, interleukin-2, and interleukin-4.
Insights
Protein engineering modifies cytokines to improve immunotherapeutic efficacy and reduce toxicity by enhancing target specificity. This approach offers new drug opportunities for cytokines like interferon and interleukins.
Area of Science:
- Immunology
- Protein Engineering
- Drug Development
Background:
- Cytokines are crucial for immune regulation but often cause toxicity or lack efficacy due to receptor pleiotropy and off-target effects.
- Understanding cytokine-receptor interactions is key to developing targeted therapies.
Purpose of the Study:
- To review the theory and practice of cytokine engineering.
- To rationalize the mechanisms of engineered cytokines based on structure.
- To highlight opportunities for engineered cytokines as immunotherapeutics.
Main Methods:
- Structure-based protein engineering of cytokines.
- Analysis of cytokine-receptor interactions.
- Review of engineered cytokine examples (interferon, IL-2, IL-4).
Main Results:
- Engineered cytokines can achieve narrowed target cell specificities, improving efficacy and reducing toxicity.
- Protein engineering provides mechanistic insights into cytokine biology and signaling.
- Structure-based design enables the development of novel cytokine-based drugs.
Conclusions:
- Cytokine engineering is a powerful strategy for developing safer and more effective immunotherapies.
- Targeted modification of cytokines like interferon, IL-2, and IL-4 holds significant therapeutic promise.
- Further research into structure-function relationships will advance cytokine-based drug discovery.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

